Personal Information
Organización/Lugar de trabajo
Milan Area, Italy Italy
Ocupación
Owner, Naxospharma; Co-owner & CSO, AESIS Therapeutics
Sector
Medical / Health Care / Pharmaceuticals
Acerca de
Professional with extensive experience in the Pharmaceutical Industry. Presently, scientist-entrepreneur.
• Backgrounds in organic synthetic chemistry, process research chemistry, medicinal chemistry.
• Demonstrated expertise in the drug discovery in important therapeutic fields by successful leadership of many result-oriented research projects.
• Creativity and strong commitment to the invention and IP protection of several therapeutical New Chemical Entities, some of which have been advanced into clinical development and into global market.
• Capacity in planning the preclinical iter of candidate compounds, from the design of viable syntheses for the scale-up process ...
Etiquetas
natural products
berberine
breast cancer
cancer
traditional chinese medicine
anticancer
chemistry of antitumour compounds
life sciences
investing
biotech
Ver más
Presentaciones
(10)Personal Information
Organización/Lugar de trabajo
Milan Area, Italy Italy
Ocupación
Owner, Naxospharma; Co-owner & CSO, AESIS Therapeutics
Sector
Medical / Health Care / Pharmaceuticals
Acerca de
Professional with extensive experience in the Pharmaceutical Industry. Presently, scientist-entrepreneur.
• Backgrounds in organic synthetic chemistry, process research chemistry, medicinal chemistry.
• Demonstrated expertise in the drug discovery in important therapeutic fields by successful leadership of many result-oriented research projects.
• Creativity and strong commitment to the invention and IP protection of several therapeutical New Chemical Entities, some of which have been advanced into clinical development and into global market.
• Capacity in planning the preclinical iter of candidate compounds, from the design of viable syntheses for the scale-up process ...
Etiquetas
natural products
berberine
breast cancer
cancer
traditional chinese medicine
anticancer
chemistry of antitumour compounds
life sciences
investing
biotech
Ver más